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Mild Cognitive Impairment (MCI) was originally conceptualized as a condition that 
manifested prior to the onset of clinical dementia, particularly Alzheimer’s disease. However, 
longitudinal studies show that MCI has an unstable course and may lead to various outcomes 
including dementia, but also stability of cognitive deficits or recovery to age appropriate 
levels of functioning. As a result, the status of MCI as a genuine diagnostic entity remains 
questionable. The aim of the present thesis was to examine the validity of the MCI concept 
by tracking groups of individuals classified into one of the MCI subtypes and to monitor their 
neuropsychological profiles over time. To avoid previous criticisms of circularity, 
participants were classified as MCI on a neuropsychological test battery and then reassessed 
longitudinally using an alternate battery of neuropsychological tests. At each stage of testing, 
participants were assessed on a comprehensive neuropsychological test battery tapping the 
cognitive domains implicated in MCI. Findings from this thesis indicate that multiple domain 
amnestic MCI may be the most valid subtype of MCI due to consistently poor performance 
over time on a range of neuropsychological measures. Results also demonstrate that those 
who are likely to remain on the MCI spectrum can be differentiated from healthy older adults 
using reliable and valid measures of sustained attention, semantic memory, verbal episodic 
memory, visual and verbal working memory, selective attention and strategy use. Despite 
these findings, evidence from this thesis indicates that existing MCI clinical criteria lack 
sufficient sensitivity and specificity. Although the concept of MCI remains useful, it cannot 
be considered a clinical diagnostic entity. Future research should prioritize the observation of 
those presenting with a multiple domain amnestic profile as these individuals may have the 
poorest prognosis. Further, studies must utilize comprehensive testing protocols to increase 
the sensitivity and specificity of identifying those with genuine subclinical impairments.
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